Cardax Stock Price, News & Analysis
Company Description
Cardax (OTC Link: CDXI) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $3.2K.
CDXI stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of CDXI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardax (CDXI) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $3.2K, CDXI is classified as a micro-cap stock with approximately 802.5K shares outstanding.
Latest News
Cardax has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings. View all CDXI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CDXI Company Profile & Sector Positioning
Cardax (CDXI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CDXI often look at related companies in the same sector, including Rebus Hldgs Inc (RBSH), Ampio Pharma (AMPE), Oncology Pharma (ONPH), Kaleido Biosciences (KLDO), and BETTER THERAPEUTICS INC (BTTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CDXI's relative position within its industry.